As we approach the end of 2020, and a year since the outbreak of COVID-19 began, cases are increasing again. We have learnt a lot about SARS-CoV-2 and our ability to test for and manage COVID-19 has improved, but ongoing debate remains about how SARS-CoV-2 is transmitted.
In September 2024, the UN General Assembly will host its second high-level meeting on antimicrobial resistance (AMR). The Global Leaders Group (GLG) on Antimicrobial Resistance…
Last week the ISHLT meeting was held in Prague, Czech Republic, where experts reported on the latest advances in lung transplantation. Findings from the use…
Immune checkpoint inhibitors such as durvalumab plus chemotherapy are first-line treatment for patients with extensive-stage small-cell lung cancer (ES-SCLC), yet durable clinical benefits are not…
In the summer of 2019, Claire (name changed for confidentiality) began to feel unwell. “I felt exhausted all the time”, she explains. “But when I…
Our recent study using data from more than 20 million participants has shown that COVID-19 vaccines consistently prevent long COVID symptoms in adults, with meta-analytic…
Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell…
Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell…
Abastumani Tuberculosis Hospital began life as a small wooden palace, high in the Caucasus Mountains, surrounded by pine trees and mist. It was built in…
Around 25 000 people die from tuberculosis every week, despite the disease being curable. Progress in reducing tuberculosis morbidity and mortality is hindered by inadequate access…
Around 25 000 people die from tuberculosis every week, despite the disease being curable. Progress in reducing tuberculosis morbidity and mortality is hindered by inadequate access…
